How thousands of British patients may have taken tainted NHS drugs sold by the mafia
Commonly prescribed drugs were stolen in Italy and then sold to British pharmacists and hospitals, exposing patients to potentially lethal consequences. Among them is statin rosuvastatin. (Source: the Mail online | Health)
Source: the Mail online | Health - June 15, 2019 Category: Consumer Health News Source Type: news

Lipitor (atorvastatin) vs. Crestor (rosuvastatin)
Title: Lipitor (atorvastatin) vs. Crestor (rosuvastatin)Category: MedicationsCreated: 5/15/2019 12:00:00 AMLast Editorial Review: 5/15/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 15, 2019 Category: Cardiology Source Type: news

Half of People Miss Benefits of Statins
Many people who are prescribed statins are at increased risk of cardiovascular disease because they stop taking the drugs. (Source: NYT Health)
Source: NYT Health - May 3, 2019 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Crestor (Drug) Cholesterol Heart Source Type: news

Lowering BP, Lipids in Healthy Elderly Has No Cognitive Effect
WEDNESDAY, Feb. 27, 2019 -- Candesartan plus hydrochlorothiazide, rosuvastatin, or their combination do not impact cognitive decline among older people, according to a study published online Feb. 27 in Neurology. Jackie Bosch, Ph.D., from McMaster... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 27, 2019 Category: Pharmaceuticals Source Type: news

The Health 202: Drug executives may have to defend these expensive medicines to Congress
Think Lyrica, Crestor, Keytruda. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - February 25, 2019 Category: Consumer Health News Authors: Paige Winfield Cunningham Source Type: news

In Latest Physical, Trump Proclaimed Healthy, but Obese In Latest Physical, Trump Proclaimed Healthy, but Obese
The president also has upped his dose of rosuvastatin to 40 mg daily.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Ezallor (Rosuvastatin Calcium Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 2, 2019 Category: Drugs & Pharmacology Source Type: news

Why the risks and benefits of statins are so complex
Statin side effects can vary depending on your age, sex and type of statin, when the cholesterol-lowering drugs are used to prevent cardiovascular disease, a new study suggests. Atorvastatin and rosuvastatin provided benefits at a lower 10-year risk. (Source: CNN.com - Health)
Source: CNN.com - Health - December 3, 2018 Category: Consumer Health News Source Type: news

Onset of Musculoskeletal Adverse Events Varies Between Statins
MONDAY, Nov. 19, 2018 -- The onset of musculoskeletal adverse events (MAEs) during statin monotherapy is significantly faster with use of atorvastatin and rosuvastatin versus simvastatin, according to a study published online Nov. 7 in Pharmacology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2018 Category: Pharmaceuticals Source Type: news

Daily aspirin not beneficial in healthy adults
Trial looks at risks and benefits of aspirin Related items fromOnMedica Too few women take part in many CVD clinical trials US doctor says FDA should have withdrawn rosuvastatin GPs defend practice on prescribing statins Drugs regulators “put profits before patients” Withdrawn valsartan meds not linked to short-term cancer risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 17, 2018 Category: UK Health Source Type: news

Aug 17, 2018 This Week in Cardiology Aug 17, 2018 This Week in Cardiology
Screening athletes, AF ablation complications, physician gender and MI mortality, the rise of chronic kidney disease, and the rosuvastatin lawsuit are discussed in this week ' s podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 17, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

AstraZeneca settles Texas drug lawsuits for $110 million
Drugmaker AstraZeneca has agreed to pay $110 million to settle two lawsuits brought by the state of Texas claiming that it fraudulently marketed the antipsychotic drug Seroquel and Crestor for high cholesterol. (Source: Reuters: Health)
Source: Reuters: Health - August 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

New drugs shine as AstraZeneca treads path back to growth
AstraZeneca's new drugs performed strongly in the second quarter, offering a glimpse of better times ahead as the company struggles with falling sales of cholesterol fighter Crestor due to generic competition. (Source: Reuters: Health)
Source: Reuters: Health - July 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

AstraZeneca sales hit by generic competitors to Crestor statin
Pharma group’s core operating profit falls 47% in first quarter (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 18, 2018 Category: Pharmaceuticals Source Type: news

Gene study spots clues to heart risk for statin patients
(Vanderbilt University Medical Center) A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2018 Category: International Medicine & Public Health Source Type: news